Yarrow Bioscience
Pre-clinicalYarrow Bioscience is a new company focused on developing a first-in-class anti-TSHR antibody for Graves’ disease and thyroid eye disease.
Founded
2020
Focus
AntibodiesBiologics
About
Yarrow Bioscience is a new company focused on developing a first-in-class anti-TSHR antibody for Graves’ disease and thyroid eye disease.
Funding History
1Total raised: $5M
Seed$5MUndisclosedJun 15, 2022
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile